Clinical trial Recruiting at 1 site Interventional Ages 30 to 75

Assessing a new questionnaire for neuropsychiatric fluctuations in Parkinson's disease

Official title: Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale (EFN)

Run by University Hospital, Grenoble · NCT06701955 · Data updated 2026-11-12

This study is testing a new questionnaire to see if it can reliably measure mood and behavior changes in people with Parkinson's disease.

More s Disease trials

Quick facts

Study typeInterventional
Ages30 Years to 75 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital, Grenoble
Academic / other
Locations1 site (Grenoble)
StatusRecruiting
StartedJanuary 30, 2025
Main results expectedFebruary 1, 2027
Study endsFebruary 1, 2027
Registry record updatedSeptember 30, 2026
Trial IDNCT06701955 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 30 to 75 with idiopathic Parkinson's disease experiencing motor fluctuations.

Probably not a fit

Patients with Parkinsonian syndromes other than idiopathic Parkinson's disease or those with significant cognitive impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the Neuropsychological Fluctuations Scale (NFS), a 20-item questionnaire designed to assess neuropsychiatric fluctuations in patients with Parkinson's disease. The research aims to establish the test-retest reliability of the NFS, which has shown promising psychometric properties in previous studies. Participants will complete the questionnaire and undergo a physical exam to ensure comprehensive evaluation. This validation step is crucial for confirming the NFS as a reliable tool for assessing non-motor symptoms in Parkinson's disease.

Why it matters

Potential benefit: If successful, this study could provide a validated tool for better assessing and managing neuropsychiatric symptoms in Parkinson's disease, ultimately improving patient care.

How similar studies have gone: Previous studies have shown promising results with similar assessment tools, indicating potential for success in this validation effort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age \> 30 and ≤ 75 years

* Idiopathic Parkinson's disease (according to the criteria of the Movement Disorders Society)
* Presence of motor fluctuations described by the patient, their relatives, or identified by the clinician
* Stability of antiparkinsonian treatment for at least one month
* Mastery of the French language
* Able to give consent.
* Affiliated to the social security system

Exclusion Criteria:

Parkinsonian syndrome other than idiopathic Parkinson's disease

* Dementia (MoCa \< 23)
* No antiparkinsonian treatment or treatment modified for less than one month
* Persons referred to in Articles L1121-5 to L1121-8 of the CSP (corresponds to all protected persons: pregnant women, parturients, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons receiving psychiatric care under Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8, persons admitted to a health or social establishment for purposes other than research, minors, persons subject to a legal protection measure or unable to express their consent))
* Subject in a period of exclusion from another interventional study.

Where it's running

  • Chuga
    Grenoble, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.